IT1317001B1 - USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS. - Google Patents

USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Info

Publication number: IT1317001B1
Authority: IT; Italy
Prior art keywords: spirolaxin; treatment; pathologies associated; altered angiogenesis; angiogenesis
Prior art date: 2000-03-13

Application number

IT2000RM000129A

Other languages

Italian (it)

Inventor

Sergio Penco

Claudio Pisano

Giuseppe Giannini

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-13

Filing date

2000-03-13

Publication date

2003-05-26

2000-03-13 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2000-03-13 Priority to IT2000RM000129A priority Critical patent/IT1317001B1/en

2000-03-13 Publication of ITRM20000129A0 publication Critical patent/ITRM20000129A0/en

2001-03-07 Priority to AU44533/01A priority patent/AU4453301A/en

2001-03-07 Priority to PCT/IT2001/000113 priority patent/WO2001068070A2/en

2001-09-13 Publication of ITRM20000129A1 publication Critical patent/ITRM20000129A1/en

2003-05-26 Application granted granted Critical

2003-05-26 Publication of IT1317001B1 publication Critical patent/IT1317001B1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IT2000RM000129A 2000-03-13 2000-03-13 USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS. IT1317001B1 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
AU44533/01A AU4453301A (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
PCT/IT2001/000113 WO2001068070A2 (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Publications (3)

Publication Number	Publication Date
ITRM20000129A0 ITRM20000129A0 (en)	2000-03-13
ITRM20000129A1 ITRM20000129A1 (en)	2001-09-13
IT1317001B1 true IT1317001B1 (en)	2003-05-26

Family

ID=11454527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.

Country Status (3)

Country	Link
AU (1)	AU4453301A (en)
IT (1)	IT1317001B1 (en)
WO (1)	WO2001068070A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20010136A1 (en) *	2001-03-16	2002-09-16	Sigma Tau Ind Farmaceuti	USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF THE PPAR-GAMMA RECEPTOR.
ITMI20041279A1 (en) *	2004-06-24	2004-09-24	Pharmaproducts Uk Ltd	USE OF TRIFLUOROACETATE CALCIUM FOR THE PREPARATION OF ANTI-ANGIOGENETIC EFFECT MEDICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996005204A1 (en) *	1994-08-09	1996-02-22	Pfizer Inc.	Spirolaxine derivatives for treating gastroduodenal diseases
JPH107557A (en) *	1996-06-17	1998-01-13	Banyu Pharmaceut Co Ltd	Spirolaxine, an antitumor substance
US6538103B1 (en) *	1998-07-14	2003-03-25	Bristol--Myers Squibb Company	Lysine binding fragments of angiostatin

2000
- 2000-03-13 IT IT2000RM000129A patent/IT1317001B1/en active
2001
- 2001-03-07 WO PCT/IT2001/000113 patent/WO2001068070A2/en active Application Filing
- 2001-03-07 AU AU44533/01A patent/AU4453301A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU4453301A (en)	2001-09-24
WO2001068070A8 (en)	2001-11-08
ITRM20000129A1 (en)	2001-09-13
WO2001068070A3 (en)	2002-04-18
WO2001068070A2 (en)	2001-09-20
ITRM20000129A0 (en)	2000-03-13

Publication	Publication Date	Title
DE50112057D1 (en)	2007-04-05	Cleaning-friendly glass ceramic body
FI20001914A0 (en)	2000-08-30	The electrode structure
EP1174399A4 (en)	2003-04-02	CERAMIC STRUCTURE
NL1017973A1 (en)	2001-11-13	Design.
NL1019181A1 (en)	2002-04-18	Stabilized metallocene-polypropylene.
FI991360L (en)	2000-12-15	Starting the guiding service
IT249776Y1 (en)	2003-05-28	MONOLITHIC THROUGH INSULATOR
IT1317001B1 (en)	2003-05-26	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
ITTO20011197A0 (en)	2001-12-20	ORNAMENTAL CYLINDRICAL BODY.
IT1306193B1 (en)	2001-05-30	USE OF ULTRASOUNDS FOR THE TREATMENT OF DADECOMPRESSION SYMPTOMATOLOGY.
ATE278659T1 (en)	2004-10-15	O-DESMETHYLVENLAFAXIN ETHER
IT1317869B1 (en)	2003-07-15	SHOWER.
ITAR990019V0 (en)	1999-07-13	DRAWN DRAWING WITH CODULO.
ES1048246Y (en)	2001-12-01	CERAMIC PIECE.
IT246402Y1 (en)	2002-04-08	THE MATTRESS OF THE REST.
FIU20000034U0 (en)	2000-01-27	The tune-changing mechanism of the kantele
IT1320746B1 (en)	2003-12-10	GO UP THE CHANDELIER.
IT249404Y1 (en)	2003-05-07	CHAIR STRUCTURE.
ITRM990326A0 (en)	1999-05-24	IMPROVED NEBULIZER.
IT1318461B1 (en)	2003-08-25	EXTENDABLE TABLE.
ITGE990120A1 (en)	2001-03-30	CUP WITH TOWEL.
ITRM20000040V0 (en)	2000-03-06	EASY PLAYNET.
ES1049547Y (en)	2002-04-16	IMPROVED SUPPORT STRUCTURE.
ITMI20001600A0 (en)	2000-07-14	PROCEDURE FOR THE PREPARATION OF 5-AMINO-4-ALO-3-ALKYL ISOXAZOLES.
ES1050534Y (en)	2002-08-01	TOILET WITH BRUSH INCORPORATED.